Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
9 Months Ended
Jun. 30, 2019
Aug. 14, 2019
Document And Entity Information    
Entity Registrant Name NeuBase Therapeutics, Inc.  
Entity Central Index Key 0001173281  
Document Type 10-Q  
Entity File Number 333-88480  
Entity Incorporation, State Code DE  
Document Period End Date Jun. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --09-30  
Entity's Reporting Status Current Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   17,070,373
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019